# Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)

> **NCT03305536** · PHASE2 · UNKNOWN · sponsor: **Hopital St. Georges, Ajaltoun** · enrollment: 150 (estimated)

## Conditions studied

- Aortic Valve Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Vitamin K2 (Menaquinone 7) + Vitamin D3

## Key facts

- **NCT ID:** NCT03305536
- **Lead sponsor:** Hopital St. Georges, Ajaltoun
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2018-01-02
- **Primary completion:** 2020-12
- **Final completion:** 2020-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2019-08-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03305536

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03305536, "Decalcification of the Aortic Valve by Vitamin K2 (Menaquinone-7)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03305536. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*